Stocks Comparison
U S Physical Therapy vs GeneDx: revenue, profit, margins and growth compared
U S Physical Therapy brought in $781M of revenue in fiscal 2025, GeneDx $427.5M in fiscal 2025. Revenue changed by +16.3% at U S Physical Therapy and +40.0% at GeneDx on the year before, so GeneDx grew faster. U S Physical Therapy kept 5.1% of its revenue as net profit, GeneDx -4.9%. Free cash flow was $61M at U S Physical Therapy and $14.3M at GeneDx.
Side by side, latest fiscal year
| USPH | WGS | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $781M | $427.5M |
| Revenue growth | +16.3% | +40.0% |
| Net income | $39.6M | -$21M |
| Net margin | 5.1% | -4.9% |
| Free cash flow | $61M | $14.3M |
| Free cash flow margin | 7.8% | 3.3% |
| Earnings per share (diluted) | $1.42 | -$0.73 |
| Cash | $35.6M | $105M |
| Debt | $162.5M | $54.5M |
| Price to earnings | 59.8 | n/a |
| Market value | $1.3B | $2.6B |
| Dividend yield | 2.12% | n/a |
| Rank by revenue in sector | #163 of 523 · Health care | #199 of 523 · Health care |
Over the years
Questions about U S Physical Therapy and GeneDx
Which is bigger by revenue, U S Physical Therapy or GeneDx?
U S Physical Therapy is bigger by revenue: $781M in fiscal 2025, against $427.5M for GeneDx in fiscal 2025.
Which keeps more of its revenue as profit, U S Physical Therapy or GeneDx?
U S Physical Therapy had a net margin of 5.1% in fiscal 2025; GeneDx had -4.9% in fiscal 2025.
Which grew revenue faster, U S Physical Therapy or GeneDx?
In their latest fiscal years revenue changed by +16.3% at U S Physical Therapy and +40.0% at GeneDx.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.